Skip to main content
BB Biotech AG logo

BB Biotech AG — Investor Relations & Filings

Ticker · BION ISIN · CH0027659793 LEI · 391200MBZQNPFHIVKO34 SW Financial and insurance activities
Open in API
Filings indexed 270 across all filing types
Latest filing 2026-06-15 Declaration of Voting R…
Country CH Switzerland
Listing SW BION

About BB Biotech AG

https://www.bbbiotech.ch/en/bb-biotech

BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a brief announcement detailing the total voting rights of BB BIOTECH AG as per Article 41 of the German Securities Trading Act (WpHG). It states the new total number of voting rights without providing broader financial data or reporting. This type of document corresponds to official disclosure of voting rights totals rather than comprehensive reports or detailed financial disclosures. According to the filing definitions, announcements of voting results or total voting rights fall under the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is short and focused on this announcement, fitting well within the DVA classification.
2026-06-15 English
EQS-NVR: BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'EQS Total Voting Rights Announcement' and specifically references a total number of voting rights and a capital measure under Sec. 41 of the WpHG (German Securities Trading Act). The text indicates it is an announcement of the new total number of voting rights as of June 15, 2026. The content focuses on reporting changes regarding voting rights, not containing financial statements, management commentary, or other report details. Thus, it fits the category of Declaration of Voting Results & Voting Rights Announcements.
2026-06-15 English
EQS-NVR: BB BIOTECH AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'EQS Gesamtstimmrechtsmitteilung' and concerns the publication of the total number of voting rights (Gesamtzahl der Stimmrechte) under section 41 of the WpHG, a European regulatory requirement for disclosure of voting rights. It contains details such as the issuer's name (BB BIOTECH AG), address, date of effectiveness (15.06.2026), and the new total number of voting rights. There is no financial data, financial results, or report content, only a disclosure of voting rights totals. This fits the definition of a 'Declaration of Voting Results & Voting Rights Announcements' which involves official results from shareholder votes or announcements related to voting rights. The document is under 2,000 characters and is a regulatory announcement about voting rights. Therefore, the correct classification is DVA.
2026-06-15 German
BB Biotech AG publishes its interim report
Report Publication Announcement Classification · 91% confidence The document is an ad-hoc announcement under Art. 53 LR stating that BB Biotech AG has published its interim report as at March 31, 2026 and provides a link to the full report. The interim report itself is not included; only its publication is announced. This fits the definition of a Report Publication Announcement (RPA).
2026-04-24 English
EQS-Adhoc: BB Biotech AG publishes its interim report
Report Publication Announcement Classification · 90% confidence The document is a short ad hoc regulatory announcement (Art. 53 LR) of BB Biotech AG stating that its interim report as of March 31, 2026 has been published and provides a link to download it. It does not contain the full interim report itself, but merely announces its publication. Under the “menu vs. meal” rule, such a brief notice is categorized as a Report Publication Announcement (RPA).
2026-04-24 English
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
Report Publication Announcement Classification · 85% confidence The document is an ad-hoc news release (Art. 53 KR) under 5,000 characters that summarizes Q1 results and states that the interim report as of March 31, 2026 is now published and available on the website. It does not contain the full interim financial report itself, but serves to announce its publication. According to the “menu vs meal” rule and definitions, this is a Report Publication Announcement (RPA).
2026-04-24 German

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.